Asaphysician, I have witnessed countlessmedicalbreakthroughs that have transformed patient careand improved lives. One such innovation istheadvent ofGLP-1agonists,aclass of medications initially developed to treat type 2 diabetes but have since gained unprecedented popularity fortheir efficacy in weight loss.
These drugs, suchas semaglutide, have garneredattention fortheirability to help people shed significantamounts of weight, improve blood sugar control,and reducetherisk of cardiovascular disease. However, whilethebenefitsare undeniable,therapidadoption ofthese medications raises concernsabout potential long-term consequences, dependency,andthebroader implications for our relationship with foodandhealth.
GLP-1agonistswork by mimickingtheaction ofthehormone glucagon-like peptide-1, which increases insulin secretion, decreases glucagon releaseand slows gastric emptying. This results in reducedappetite, increased satiety,and improved glycemic control, makingthese medications incredibly effective for weight lossand managing diabetes.
For individuals who have struggled with weight loss through diet and exercise alone, these medications offer hope and a tangible solution. (Joel Saget/AFP via Getty Images)
Clinical trials have shown that patients onthese medications can lose up to 15-20% oftheir body weight,aresult previouslyachievable only through bariatric surgery.
Theimplications of this weight lossare profound. Obesity isamajor risk factor for numerous chronic diseases, including type 2 diabetes, cardiovascular diseaseand certain cancers. By helping patients lose weight,GLP-1agonistscan reducetheincidence ofthese conditions, potentially saving livesand reducingtheburden onhealthcare systems.
For individuals who have struggled with weight loss through dietand exercisealone,these medications offer hopeandatangible solution.
However,thevery effectiveness ofGLP-1agonistsalso raises red flags.As more people turn tothese drugs for weight loss,there isagrowing concern that we may be fosteringadependency on medication rather thanaddressingtheroot causes of obesity.
OZEMPIC PATIENTS MAY FACE DANGEROUS RISKS DURING SURGERY, DOCTORS WARN
Unlike lifestyle changes, which require ongoing effortand can lead to sustainable weight management,GLP-1agonistsofferaquick fix that may lead to complacency inadoptinghealthier behaviors. Patients may become reliant onthese medications to maintaintheir weight, creatingascenario wheretheyare dependent onadrug forthelong term.
Limited studiesalready show that onaverage, people gain back two-thirds oftheweightthey’ve lost withinayear of stoppingthemedication, with some people consuming more daily calories than beforethey beganthemedication.
Also,thelong-term safety ofGLP-1agonistsis still unknown. Whilethese drugs have been shown to be safeand effective in clinical trials,these studies typically last onlyafew years. We do not yet have data ontheeffects of takingthese medications for decades, so it is concerning that peopleare being prescribedthem withoutan end date. Couldthere be unforeseen side effectsorhealthrisks that emerge over time?
OZEMPIC AND OTHER GLP-1 DRUGS COULD REDUCE ARTHRITIS SYMPTOMS IN SOME, EXPERTS CLAIM
Therearealready known risks tothese medications, nausea beingthemost common to intestinal blockages, which can be fatal.Animal studies suggestapossible risk of thyroid cancer withthese medications, but it will take long-term data to know if this translates to humansas well.
Thehistory of medicine is replete with examples of drugs that were initially hailedas breakthroughs but later found to have serious consequences.Theopioidcrisis, which began withthewidespread prescription of what were thought to be safe painkillers, servesasastark reminder ofthepotential dangers of over-reliance on medication.
Beyondthephysical risks,therearealso psychologicaland social implications to consider.Theuse ofGLP-1agonistsmay reinforce unhealthy relationships with foodand body image. Rather than viewing foodas nourishmentand embracingabalancedapproach to eating, individuals may come to see foodas something to be controlledorfeared. This could exacerbate issues like disordered eatingorbody dysmorphia, particularly inasociety thatalready places immense pressure on individuals to conform to certain body ideals.
CLICK HERE FOR MORE FOX NEWS OPINION
Likewise,thewidespread use ofthese medications could contribute toasocietal shift in how weapproachhealthand wellness. Instead of focusing on preventionand naturalapproaches tohealth,there isarisk that we may increasingly turn to pharmaceutical solutionsasthefirst line of defense. Is thisthemessage we want to be teaching our children? This could undermine efforts to promotehealthy lifestylesand diminishthevalue of interventions like diet, exercise,and mental well-being.
Thecomparison totheopioid epidemic is not made lightly. WhileGLP-1agonistsare notaddictive inthesame way that opioidsare,theaddiction to havingaslimmer body imageandthepotential for widespread dependency, coupled with unknown long-term risks, suggests that we should proceed with caution.
Ashealthcare providers, we havearesponsibility to ensure that weare not simply replacing one publichealthcrisiswithanother.
Therise ofGLP-1agonistspresentsacomplex challenge. On one hand,these medications offer significant benefits for weight lossand chronic disease management. Ontheother,they raise concernsabout dependency, long-term safetyandthebroader impact on ourapproach tohealth.
As we navigate this new trend in weight loss, it is crucial that we remain vigilant, prioritize patient educationand encourage short-term use with maintenance lifestyle changes.Thepromise ofGLP-1agonistsis real, but so tooaretherisks. Let us not repeatthemistakes ofthepast byallowingapromisingmedicaladvance to evolve intothenexthealthcrisis.
CLICK HERE TO READ MORE FROM NICOLE SAPHIER
Nicole Saphier, M.D., is a board certified radiologist with advanced fellowship training in breast imaging, Fox News medical contributor and bestselling author. Her new book is “Love, Mom.” She is also the bestselling author of “Make America Healthy Again” and “Panic Attack: Playing Politics with Science in the Fight Against COVID-19.” Follow her on X, formerly known as Twitter @NBSaphierMD and Instagram @nicolesaphier_md.

Video
Video
Video
Video
Video
Leave a Reply